Featured News
news cover
SKYRIZI® (risankizumab) Receives Positive Reimbursement Recommendation by Canada’s Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance
5 hours ago
news cover
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
5 hours ago
news cover
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
30 Nov 2025
news cover
Junshi Biosciences Announces Primary Endpoints Met in JS001sc’s Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
30 Nov 2025
View more
Global Express
6 hours ago
Meeting patients where they are: tailored support to drive recruitment and retention
Clinical Study
12 hours ago
Gene writing startup Tessera strikes $150M partnership with Regeneron
AcquisitionClinical StudyGene Therapy
13 hours ago
Generate to launch Phase 3 TSLP drug studies, as AI bio enters its clinical era
Phase 3Phase 1Clinical ResultPhase 2ADC
13 hours ago
Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel
Drug ApprovalAcquisitionPhase 1Accelerated Approval
14 hours ago
Regeneron bets $275M on Tessera's AATD gene-writing fix
Gene TherapyClinical StudyLicense out/inASH
View more
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
May 2025 Patent Highlights
May 2025 Patent Highlights
Patsnap Synapse
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
Patsnap Synapse
Global Drug R&D Express (February 2025)
Global Drug R&D Express (February 2025)
PatSnap Synapse
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.